sr141716 has been researched along with Tuberculosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, X; Guddat, LW; Jiang, B; Jiang, H; Li, J; Liu, Z; Rao, Z; Wu, L; Yang, H; Yang, X; Yang, Y; Zhang, B; Zhang, J; Zhang, L; Zhao, Y | 1 |
1 other study(ies) available for sr141716 and Tuberculosis
Article | Year |
---|---|
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target.
Topics: Adamantane; Antitubercular Agents; Bacterial Proteins; Biological Transport; Drug Delivery Systems; Drug Design; Ethylenediamines; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenylurea Compounds; Rimonabant; Tuberculosis | 2019 |